Wealth Enhancement Advisory Services LLC Grows Position in Revvity Inc. $RVTY

Wealth Enhancement Advisory Services LLC lifted its holdings in Revvity Inc. (NYSE:RVTY) by 4.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,352 shares of the company’s stock after buying an additional 213 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in Revvity were worth $542,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently bought and sold shares of the business. Price T Rowe Associates Inc. MD raised its stake in Revvity by 25.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 9,563,911 shares of the company’s stock worth $1,011,863,000 after purchasing an additional 1,932,314 shares during the period. T. Rowe Price Investment Management Inc. raised its position in shares of Revvity by 8.5% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 22,515,711 shares of the company’s stock valued at $2,382,163,000 after buying an additional 1,754,403 shares during the period. EdgePoint Investment Group Inc. raised its position in shares of Revvity by 32.1% during the 1st quarter. EdgePoint Investment Group Inc. now owns 5,360,847 shares of the company’s stock valued at $567,178,000 after buying an additional 1,302,616 shares during the period. Nuveen LLC acquired a new position in Revvity in the first quarter valued at approximately $28,060,000. Finally, Jennison Associates LLC acquired a new stake in Revvity during the first quarter worth $27,282,000. Hedge funds and other institutional investors own 86.65% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the company. Wall Street Zen lowered Revvity from a “buy” rating to a “hold” rating in a research note on Sunday, August 3rd. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Revvity in a research report on Saturday, September 27th. Evercore ISI dropped their price target on shares of Revvity from $116.00 to $115.00 and set an “outperform” rating for the company in a research report on Tuesday, July 8th. Bank of America reduced their price target on shares of Revvity from $110.00 to $99.00 and set a “buy” rating on the stock in a research note on Monday, September 22nd. Finally, Stifel Nicolaus lowered their price objective on shares of Revvity from $120.00 to $110.00 and set a “hold” rating for the company in a research report on Tuesday, July 29th. Ten investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $118.57.

Revvity Stock Up 3.0%

RVTY stock opened at $94.17 on Monday. The company’s 50 day moving average price is $88.08 and its 200 day moving average price is $93.30. The firm has a market capitalization of $10.93 billion, a price-to-earnings ratio of 39.90, a PEG ratio of 3.14 and a beta of 0.98. Revvity Inc. has a fifty-two week low of $81.36 and a fifty-two week high of $129.50. The company has a debt-to-equity ratio of 0.43, a quick ratio of 2.75 and a current ratio of 3.33.

Revvity (NYSE:RVTY) last posted its quarterly earnings results on Monday, July 28th. The company reported $1.18 EPS for the quarter, topping the consensus estimate of $1.14 by $0.04. Revvity had a net margin of 10.19% and a return on equity of 7.66%. The company had revenue of $720.28 million during the quarter, compared to analysts’ expectations of $711.26 million. During the same quarter in the previous year, the business posted $1.22 EPS. The firm’s revenue was up 4.1% on a year-over-year basis. Revvity has set its FY 2025 guidance at 4.850-4.950 EPS. On average, equities research analysts anticipate that Revvity Inc. will post 4.94 EPS for the current fiscal year.

Revvity Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 7th. Investors of record on Friday, October 17th will be issued a $0.07 dividend. This represents a $0.28 annualized dividend and a yield of 0.3%. The ex-dividend date of this dividend is Friday, October 17th. Revvity’s dividend payout ratio is 11.86%.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.